Search for: All records

The human auditory system consists of both peripheral and central components, both of which play a role but contribute distinctly to overall auditory functioning and can be differentially impacted by pathophysiologic states. Hemispheric surgery (HS), a procedure used for the treatment of drug-resistant epilepsy, involves com- plete disconnection of the auditory cortex in the operative hemisphere, leaving hearing acuity (peripheral function) intact but having heavy implications for auditory processing (central function). The literature describing pre- and post-operative auditory processing abilities of individuals who have undergone HS is sparse, but the research available provides evidence that several central auditory processes including auditory spatial analysis and temporal processing may be impacted. De昀椀cits noted in standardized testing within the clinical or research environment have concrete functional impacts that may be currently under-appreciated and could lead to under-utilization of appropriate therapeutic strategies and accommodations. This review describes the pro昀椀le of central auditory processing abilities in patients who have undergone HS by synthesizing available literature and incorporating research in other clinical populations to help 昀椀ll critical gaps in our understanding of how cerebral disconnection impacts the central auditory system. 

The diverse T cell receptor (TCR) repertoire confers the ability to recognize an almost unlimited array of antigens. Characterization of antigen specificity of tumor-infiltrating lymphocytes (TILs) is key for understanding antitumor immunity and for guiding the development of effective immunotherapies. Here, we report a large-scale comprehensive examination of the TCR landscape of TILs across the spectrum of pediatric brain tumors, the leading cause of cancer-related mortality in children. We show that a T cell clonality index can inform patient prognosis, where more clonality is associated with more favorable outcomes. Moreover, TCR similarity groups’ assessment revealed patient clusters with defined human leukocyte antigen associations. Computational analysis of these clusters identified putative tumor antigens and peptides as targets for antitumor T cell immunity, which were functionally validated by T cell stimulation assays in vitro. Together, this study presents a framework for tumor antigen prediction based on in situ and in silico TIL TCR analyses. We propose that TCR-based investigations should inform tumor classification and precision immunotherapy development.